Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand.
Intawong K, Chariyalertsak S, Chalom K, Wonghirundecha T, Kowatcharakul W, Thongprachum A, Chotirosniramit N, Noppakun K, Khwanngern K, Teacharak W, Piamanant P, Khammawan P, Iamsirithaworng S. Intawong K, et al. Among authors: kowatcharakul w. J Microbiol Immunol Infect. 2023 Dec;56(6):1178-1186. doi: 10.1016/j.jmii.2023.10.001. Epub 2023 Oct 18. J Microbiol Immunol Infect. 2023. PMID: 37880062 Free article.
Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand.
Intawong K, Chariyalertsak S, Chalom K, Wonghirundecha T, Kowatcharakul W, Ayood P, Thongprachum A, Chotirosniramit N, Noppakun K, Khwanngern K, Teacharak W, Piamanant P, Khammawan P. Intawong K, et al. Among authors: kowatcharakul w. Int J Infect Dis. 2023 Jan;126:31-38. doi: 10.1016/j.ijid.2022.11.006. Epub 2022 Nov 11. Int J Infect Dis. 2023. PMID: 36372363 Free PMC article.
Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: a test-negative, case-control study.
Intawong K, Chariyalertsak S, Chalom K, Wonghirundecha T, Kowatcharakul W, Thongprachum A, Chotirosniramit N, Teacharak W, Pimpinan Khammawan, Waneesorn J, Iamsirithaworn S. Intawong K, et al. Among authors: kowatcharakul w. Lancet Reg Health Southeast Asia. 2023 Mar;10:100121. doi: 10.1016/j.lansea.2022.100121. Epub 2022 Nov 29. Lancet Reg Health Southeast Asia. 2023. PMID: 36465090 Free PMC article.
Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand.
Intawong K, Chariyalertsak S, Chalom K, Wonghirundecha T, Kowatcharakul W, Thongprachum A, Chotirosniramit N, Noppakun K, Khwanngern K, Teacharak W, Piamanant P, Chantaklang P, Khammawan P. Intawong K, et al. Among authors: kowatcharakul w. PLoS One. 2023 May 11;18(5):e0284130. doi: 10.1371/journal.pone.0284130. eCollection 2023. PLoS One. 2023. PMID: 37167215 Free PMC article.
Mental health circumstances among health care workers and general public under the pandemic situation of COVID-19 (HOME-COVID-19).
Nochaiwong S, Ruengorn C, Awiphan R, Ruanta Y, Boonchieng W, Nanta S, Kowatcharakul W, Pumpaisalchai W, Kanjanarat P, Mongkhon P, Thavorn K, Hutton B, Wongpakaran N, Wongpakaran T; Health Outcomes and Mental Health Care Evaluation Survey Research Group (HOME-Survey). Nochaiwong S, et al. Among authors: kowatcharakul w. Medicine (Baltimore). 2020 Jun 26;99(26):e20751. doi: 10.1097/MD.0000000000020751. Medicine (Baltimore). 2020. PMID: 32590751 Free PMC article.
Awareness and preparedness of healthcare workers against the first wave of the COVID-19 pandemic: A cross-sectional survey across 57 countries.
Huy NT, Chico RM, Huan VT, Shaikhkhalil HW, Uyen VNT, Qarawi ATA, Alhady STM, Vuong NL, Truong LV, Luu MN, Dumre SP, Imoto A, Lee PN, Tam DNH, Ng SJ, Hashan MR, Matsui M, Duc NTM, Karimzadeh S, Koonrungsesomboon N, Smith C, Cox S, Moji K, Hirayama K, Linh LK, Abbas KS, Dung TNT, Mohammed Ali Al-Ahdal T, Balogun EO, Duy NT, Mohamed Eltaras M, Huynh T, Hue NTL, Khue BD, Gad A, Tawfik GM, Kubota K, Nguyen HM, Pavlenko D, Trang VTT, Vu LT, Hai Yen T, Yen-Xuan NT, Trang LT, Dong V, Sharma A, Dat VQ, Soliman M, Abdul Aziz J, Shah J, Hung PDL, Jee YS, Phuong DTH, Quynh TTH, Giang HTN, Huynh VTN, Thi NA, Dhouibi N, Phan T, Duru V, Nam NH, Ghozy S; contributors of the TMGH-Global COVID-19 Collaborative; TMGH-Global COVID-19 Collaborative. Huy NT, et al. PLoS One. 2021 Dec 22;16(12):e0258348. doi: 10.1371/journal.pone.0258348. eCollection 2021. PLoS One. 2021. PMID: 34936646 Free PMC article.
Temporal trend in quality indicators of diabetes care performance among persons with type 2 diabetes in primary care practice: a serial cross-sectional analytical study, 2013/14 to 2021/22.
Awiphan R, Kowatcharakul W, Ruengorn C, Noppakun K, Thavorn K, Nochaiwong S. Awiphan R, et al. Among authors: kowatcharakul w. Front Endocrinol (Lausanne). 2024 Oct 23;15:1359904. doi: 10.3389/fendo.2024.1359904. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39507052 Free PMC article.
Role of booster vaccines and hybrid immunity against severe COVID-19 outcomes during BA.5 omicron predominance in Thailand.
Intawong K, Chariyalertsak S, Chalom K, Wonghirundecha T, Kowatcharakul W, Thongprachum A, Chotirosniramit N, Noppakun K, Khwanngern K, Teacharak W, Piamanant P, Chantaklang P, Khammawan P. Intawong K, et al. Among authors: kowatcharakul w. Hum Vaccin Immunother. 2023 Dec 15;19(3):2291882. doi: 10.1080/21645515.2023.2291882. Epub 2023 Dec 11. Hum Vaccin Immunother. 2023. PMID: 38083848 Free PMC article.